Advisory Boards

As thought leaders, we are asked to participate on a variety of advisory boards to represent the interest and perspectives of lung cancer patients.

We are honored to serve as members on:

  • ACCC Advisory Committee - Optimal Care Coordination Model for Medicaid Patients with Lung Cancer (2016 – present)
  • ACCC Advisory Committee for Molecular Testing NSCLC Initiative (2016 – present )
  • American Association for Cancer Researcher (AACR), Cancer Today Editorial Advisory Board (2016 – 2018)
  • American Cancer Society Cancer Action Network Clinical Trials Enrollment Project Steering Committee (2017 – present)
  • American Thoracic Society Public Advisory Roundtable (2017 – present)
  • Cancer Innovation Council Pathways Working Group member (2015 – present)
  • Diverse Cancer Communities Working Group for Sustainable Healthy Communities, LLC founded by the National Minority Quality Forum (2018 – present)
  • FasterCures’ Benefit-Risk Advisory Council (2015 – present)
  • FasterCures’ Patients Count Leadership Council (2018 – present)
  • Foundation for the National Institutes of Health Joint Steering Committee
  • Partnership for Accelerating Cancer Therapies (2018 – present)
  • Friends of Cancer Research Immuno-oncology Policy Working Group member (2015 – present)
  • LungMAP’s Patient Advisory Committee (2014 – present)
  • National Cancer Institute’s Council of Research Advocates (2012 – 2015)
  • National Cancer Institute’s Partnership for Accelerating Cancer Therapies (PACT) Joint Steering Committee (2018 – present)
  • National Cancer Institute’s Patient Advocate Steering Committee (2016 – 2019)
  • National Cancer Institute’s Thoracic Malignancy Steering Committee (2016 – 2019)
  • Personalized Medicine Coalition Patient Advocacy Organization Working Group (2018 – present)
  • SITC’s Cancer Immunotherapy Guidelines – Lung Cancer (CIG-LC) Task Force (2016 – present)
  • Team member of Stand Up to Cancer Lung Cancer KRAS Dream Team (2015 – 2018)

print